Evaluation of fesoterodine fumarate for the treatment of an overactive bladder

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.9, Iss.12, 2013-12, pp. : 1659-1666

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fesoterodine: a guide to its use in overactive bladder syndrome

Drugs & Therapy Perspectives, Vol. 26, Iss. 1, 2010-01 ,pp. : 5-7

Adis International

Access to resources Recommend Favorite

Tolterodine for the treatment of overactive bladder

By Salvatore Stefano Serati Maurizio Bolis Pierfrancesco

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 7, 2008-05 ,pp. : 1249-1255

Informa Healthcare

Access to resources Recommend Favorite

Imidafenacin for the treatment of overactive bladder

By Leone Roberti Maggiore Umberto Scala Carolina Venturini Pier Luigi Ferrero Simone

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 10, 2013-07 ,pp. : 1383-1397

Informa Healthcare

Access to resources Recommend Favorite

Mirabegron in the treatment of overactive bladder

By Leone Roberti Maggiore Umberto Cardozo Linda Ferrero Simone Sileo Filomena Cola Alice Torella Marco Colacurci Nicola Candiani Massimo Salvatore Stefano

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 6, 2014-04 ,pp. : 873-887

Informa Healthcare

Access to resources Recommend Favorite

Darifenacin: In the Treatment of Overactive Bladder

By Katherine F. Croom Gillian M. Keating

Drugs & Aging, Vol. 21, Iss. 13, 2004-01 ,pp. : 885-892

Adis International

Access to resources Recommend Favorite